4//SEC Filing
Nuyten Dimitry SA 4
Accession 0001209191-23-004876
CIK 0001724521other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 5:55 PM ET
Size
7.1 KB
Accession
0001209191-23-004876
Insider Transaction Report
Form 4
Nuyten Dimitry SA
Chief Medical Officer
Transactions
- Award
Common Stock
2023-01-23+34,000→ 76,500 total - Award
Stock Option (Right to Buy)
2023-01-23+138,200→ 138,200 totalExercise: $22.02Exp: 2033-01-22→ Common Stock (138,200 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2023, subject to the Reporting Person's continued service to the Company.
- [F2]The option becomes exercisable in 48 equal monthly installments after January 1, 2023, subject to the Reporting Person's continued service to the Company.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001776564
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 5:55 PM ET
- Size
- 7.1 KB